Key Points
- Director Michael Foster sold 10,000 Sabra Healthcare REIT shares at an average $20.98, worth $209,800, reducing his holdings by 12.07% to 72,834 shares.
- Sabra’s latest quarter saw earnings per share of $0.11, below the $0.16 consensus, while revenue of $249.57 million exceeded estimates and rose 31.4% year over year.
- The company declared a quarterly dividend of $0.30 per share, equivalent to $1.20 annually and a 5.8% yield. Analysts’ consensus rating is “Moderate Buy,” with a $21.67 target price.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) Director Michael Foster sold 10,000 shares of the firm's stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $20.98, for a total value of $209,800.00. Following the completion of the sale, the director directly owned 72,834 shares of the company's stock, valued at approximately $1,528,057.32. This trade represents a 12.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Sabra Healthcare REIT Price Performance
Shares of NASDAQ SBRA opened at $20.56 on Friday. The firm has a market capitalization of $5.39 billion, a P/E ratio of 73.43, a PEG ratio of 1.83 and a beta of 0.68. Sabra Healthcare REIT, Inc. has a one year low of $17.53 and a one year high of $22.77. The company's fifty day moving average is $19.89 and its two-hundred day moving average is $20.03. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.21 and a current ratio of 1.21.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.16 by ($0.05). The company had revenue of $249.57 million for the quarter, compared to analyst estimates of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. The business's revenue for the quarter was up 31.4% compared to the same quarter last year. During the same period last year, the company earned $0.38 earnings per share. Analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.20 dividend on an annualized basis and a yield of 5.8%. Sabra Healthcare REIT's payout ratio is currently 428.57%.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the stock. Huntington began coverage on shares of Sabra Healthcare REIT in a research report on Monday, November 2nd. They set a "strong-buy" rating on the stock. Raymond James Financial raised shares of Sabra Healthcare REIT from an "underperform" rating to a "market perform" rating in a report on Thursday, August 6th. Citigroup reiterated a "market outperform" rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Weiss Ratings raised Sabra Healthcare REIT from a "hold (c)" rating to a "buy (b-)" rating in a research note on Tuesday, November 3rd. Finally, Wells Fargo & Company decreased their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an "overweight" rating on the stock in a research note on Monday, October 19th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $21.67.
Read Our Latest Stock Report on Sabra Healthcare REIT
Institutional Trading of Sabra Healthcare REIT
Several large investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP raised its stake in shares of Sabra Healthcare REIT by 7.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust's stock worth $71,640,000 after buying an additional 269,793 shares during the last quarter. Readystate Asset Management LP purchased a new stake in shares of Sabra Healthcare REIT in the 2nd quarter worth about $1,400,000. Sound Income Strategies LLC boosted its position in shares of Sabra Healthcare REIT by 8.3% in the 3rd quarter. Sound Income Strategies LLC now owns 1,051,751 shares of the real estate investment trust's stock worth $19,815,000 after buying an additional 80,453 shares in the last quarter. Entropy Technologies LP boosted its position in shares of Sabra Healthcare REIT by 299.6% in the 1st quarter. Entropy Technologies LP now owns 124,068 shares of the real estate investment trust's stock worth $2,386,000 after buying an additional 93,021 shares in the last quarter. Finally, Quantinno Capital Management LP boosted its position in shares of Sabra Healthcare REIT by 424.3% in the 1st quarter. Quantinno Capital Management LP now owns 155,086 shares of the real estate investment trust's stock worth $2,982,000 after buying an additional 125,507 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.
Sabra Healthcare REIT Company Profile
(
Get Free Report)
Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company's properties are located in the United States and Canada.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
